NFKB1 and colitis: In addition, butyrate may have a key role in the development of colorectal cancer.It may partially inhibit the release of inflammatory mediators, protect the intestinal mucosal, and inhibit the development of colitis and CAC by regulating the NF-κB signaling pathway and gut microbiota.